Novel Caspase Substrates for Live Cells

Information

  • Research Project
  • 7271444
  • ApplicationId
    7271444
  • Core Project Number
    R43GM080798
  • Full Project Number
    1R43GM080798-01
  • Serial Number
    80798
  • FOA Number
    PA-06-20
  • Sub Project Id
  • Project Start Date
    9/1/2007 - 18 years ago
  • Project End Date
    2/29/2008 - 17 years ago
  • Program Officer Name
    GOLANOV, EUGENE V
  • Budget Start Date
    9/1/2007 - 18 years ago
  • Budget End Date
    2/29/2008 - 17 years ago
  • Fiscal Year
    2007
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/20/2007 - 18 years ago
Organizations

Novel Caspase Substrates for Live Cells

[unreadable] DESCRIPTION (provided by applicant): As both initiators and executioners of apoptosis, caspases serve as important drug targets for many major diseases such as neurological diseases, cardiovascular diseases, cancer, autoimmune diseases and diabetes. To date, apoptosis research highly desires cell permeable and sensitive caspase substrates for detecting caspase activation in live cells and animals. By utilizing Biotium's patented technology, we created a novel class green fluorescent caspse-3 substrate that is capable of detecting caspase activity within individual live cell in real-time, and also effectively monitoring nucleus morphology of apoptotic cells. This bi-functional caspase substrate allows studying heterogeneity of cell population during apoptosis, early detection of apoptotic cells and monitoring cellular apoptotic process kinetically. The overall goal of this Phase I SBIR grant application is develop a far-red fluorescent bi-functional caspase-3 substrate that can be used for multiplex detection together with existing popular fluorescent biomolecules such as FITC, Alexa 488, Rhodamine, Texas-red conjugates for immunostaining. [unreadable] [unreadable] Apoptosis or programmed cell death is a distinct, intrinsic cell death program that occurs in various physiological and pathological situations. Disruptions in this process play important roles in many major diseases such as neurological diseases, cancer, autoimmune diseases, diabetes, and cardiovascular diseases. As both initiators and executioners of apoptosis, caspases serve as important drug targets for these diseases. Among them, caspase-3 has been extensively studied for their important roles in apoptosis and necrosis in many tissues. The development of multi- color cell permeable and sensitive caspase substrates described in this project will allows studying caspase-3 activation in live cells and correlation of caspase-3 activation with other cellular events. They also provide novel tools for directly screening caspase inhibitors or activators in live cells. These novel caspase substrates will greatly facilitate our understanding of apoptosis and its relation to various diseases and the development of future therapeutics for apoptosis related diseases. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    132199
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:132199\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BIOTIUM, INC.
  • Organization Department
  • Organization DUNS
    806639394
  • Organization City
    HAYWARD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    945453829
  • Organization District
    UNITED STATES